Last reviewed · How we verify
Dapagliflozin or Empagliflozin
Dapagliflozin or Empagliflozin is a Small molecule drug developed by Yonsei University. It is currently FDA-approved.
At a glance
| Generic name | Dapagliflozin or Empagliflozin |
|---|---|
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors
- Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (PHASE4)
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide. (NA)
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (NA)
- Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors
- Effect of SGLT2 Inhibitors on Anemic CKD Patients
- Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dapagliflozin or Empagliflozin CI brief — competitive landscape report
- Dapagliflozin or Empagliflozin updates RSS · CI watch RSS
- Yonsei University portfolio CI
Frequently asked questions about Dapagliflozin or Empagliflozin
What is Dapagliflozin or Empagliflozin?
Dapagliflozin or Empagliflozin is a Small molecule drug developed by Yonsei University.
Who makes Dapagliflozin or Empagliflozin?
Dapagliflozin or Empagliflozin is developed and marketed by Yonsei University (see full Yonsei University pipeline at /company/yonsei-university).
What development phase is Dapagliflozin or Empagliflozin in?
Dapagliflozin or Empagliflozin is FDA-approved (marketed).
Related
- Manufacturer: Yonsei University — full pipeline
- Compare: Dapagliflozin or Empagliflozin vs similar drugs
- Pricing: Dapagliflozin or Empagliflozin cost, discount & access